CACNA2D1 and nasopharyngeal carcinoma: Three EBV+ NPC cell lines showed protein expression of CACNA2D1, but expression was absent in normal control NP69 cells, indicating that CACNA2D1 could be a good therapeutic target (Figure 3D).